Therapies At Cardinal Health News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Therapies at cardinal health. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Therapies At Cardinal Health Today - Breaking & Trending Today

Biosimilars in Retina Space Expected to Grow in 2024, Coming Years

In a review, investigators focused on ranibizumab (Lucentis; Genentech), aflibercept (Eylea; Regeneron), and bevacizumab (Avastin; Genentech) as growth opportunities in the biosimilar space. ....

United States , P Biocon Biologics , Samsung Bioepis , Fran Gregory , Coherus Biosciences , Therapies At Cardinal Health , Momenta Pharmaceuticals , Pivotal Year , Pharmacy Times , Emerging Therapies , Cardinal Health , Biocon Biologics , Ophthalmology Times , Outlook Therapeutics , Federal Food , Shanghai Henlius Biotech , Big Year , Biologics License Application ,

Expert: Though Patients Don't Always See Savings With Biosimilars, New Policies Could Improve Access

Fran Gregory, PharmD, MBA, vice president of Emerging Therapies at Cardinal Health, discussed the role biosimilars are playing in the pharmaceutical market as well as in patient access. ....

White House , District Of Columbia , United States , Fran Gregory , Therapies At Cardinal Health , Pharmacy Times , Specialty Pharmacy Summit , Emerging Therapies , Cardinal Health ,

Expert: Pharmacy, Medical Benefit Adoption of Biosimilars Present Different Challenges

Fran Gregory, PharmD, MBA, vice president of Emerging Therapies at Cardinal Health, discussed the biosimilars landscape and where biosimilars fall in the process of pharmacy and medical benefit adoption. ....

Fran Gregory , Therapies At Cardinal Health , Pharmacy Times , Emerging Therapies , Cardinal Health , Oncology Care Model ,